Next Article in Journal
Quantitative Assessment of Extrinsic Tongue Muscle Stiffness in Obstructive Sleep Apnea Using Shear Wave Elastography
Previous Article in Journal
Heart Sound Classification with MFCCs and Wavelet Daubechies Analysis Using Machine Learning Algorithms
Previous Article in Special Issue
Analysis of the Reasons for Poor Prognosis in Severe to Profound Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-Analysis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence and Interplay of Modifiable and Genetic Determinants of Eustachian Tube Dysfunction Among Saudi Adults: A Nationwide Study

by
Mohammad A. Jareebi
1,*,
Riyadh A. Jahlan
2,
Abdulrahman A. Otaif
2,
Abdulelah A. Otaif
2,
Abdulrahman A. Daghreeri
2,
Mashael S. Mahnashi
3,
Raghad W. Al Nahwe
3,
Yahya A. Maslamani
4,
Ali Y. Mashragi
5,
Abdullah Mawkili
6,
Wedad Mawkili
7,
Faisal Hakami
5,
Sulaiman Ahmed Hussain Darbashi
8,
Majed A. Ryani
1 and
Ahmed A. Bahri
1
1
Department of Family and Community Medicine, Faculty of Medicine, Jazan University, Jazan 45142, Saudi Arabia
2
Faculty of Medicine, Jazan University, Jazan 45142, Saudi Arabia
3
Department of Otolaryngology-Head and Neck Surgery, King Saud University Medical City, Riyadh 11461, Saudi Arabia
4
Public Health Authority–Southern Sector, Jazan 45142, Saudi Arabia
5
Department of Otorhinolaryngology-Head and Neck Surgery, Jazan Health Cluster, Jazan 45142, Saudi Arabia
6
Department of Surgery, Faculty of Medicine, Jazan University, Jazan 45142, Saudi Arabia
7
Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia
8
Department of Otorhinolaryngology, Jazan General Hospital, Jazan Health Cluster, Jazan 45142, Saudi Arabia
*
Author to whom correspondence should be addressed.
Diagnostics 2026, 16(1), 86; https://doi.org/10.3390/diagnostics16010086
Submission received: 30 October 2025 / Revised: 6 December 2025 / Accepted: 9 December 2025 / Published: 26 December 2025

Abstract

Background/Objectives: Eustachian Tube Dysfunction (ETD) is a prevalent condition affecting middle ear pressure regulation, yet nationwide epidemiological data in Saudi Arabia remain limited. This study aimed to assess the prevalence of ETD and identify its associated factors among Saudi adults using a validated screening tool. Methods: A nationwide cross-sectional study was conducted between June 2024 and March 2025 among 1124 Saudi adults (aged ≥ 18 years) across five geographic regions. ETD was assessed using the validated Arabic version of the seven-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7), with scores ≥ 14.5 indicating dysfunction. Data on demographic, anthropometric, clinical, and lifestyle characteristics were collected via an online questionnaire. Multiple linear regression analysis identified independent predictors of ETDQ-7 scores, with statistical significance set at p < 0.05. Results: The prevalence of ETD was 33.9% (95% CI: 31.1–36.8%), substantially higher than the 7% self-reported rate. Of affected participants, 29.6% had mild-to-moderate ETD and 4.3% had severe dysfunction. Multivariable regression analysis identified four significant independent predictors: higher body mass index (BMI) (β = 0.08; 95% CI: 0.03–0.16; p = 0.049), family history of hearing loss (β = 1.87; 95% CI: 0.90–2.83; p < 0.001), prior bariatric bypass surgery (β = 14.37; 95% CI: 3.33–25.41; p = 0.011), and allergies (β = 3.19; 95% CI: 2.30–4.07; p < 0.001). No significant associations were found with demographic factors, smoking, or other comorbidities. Conclusions: ETD affects approximately one-third of Saudi adults, with significant underdiagnosis. Obesity, genetic predisposition, bariatric surgery, and allergic conditions represent key modifiable and non-modifiable risk factors. These findings support implementing routine ETDQ-7 screening in primary care and targeted interventions for high-risk populations.

1. Introduction

The Eustachian tube (ET) is a narrow anatomical conduit connecting the middle ear to the nasopharynx, serving three essential physiological functions: regulation of middle ear pressure, ventilation of the tympanic cavity, and clearance of secretions through mucociliary action [1,2]. Additionally, it prevents the reflux of nasopharyngeal secretions and sound into the middle ear [1]. When these functions become impaired, the resulting condition is termed Eustachian Tube Dysfunction (ETD) [3]. ETD represents a common otological disorder that predisposes individuals to various middle ear pathologies, including otitis media with effusion (OME), tympanic membrane atelectasis, and cholesteatoma, potentially leading to conductive hearing loss and significant morbidity [4,5]. Globally, ETD affects approximately 5% of adults and up to 40% of children, with transient dysfunction being particularly common during early developmental stages [6,7]. In the United States alone, ETD accounts for over 2 million annual outpatient visits among adults aged 20 years and older, reflecting its substantial clinical and economic burden [3]. Despite its high prevalence, ETD remains underdiagnosed due to nonspecific symptoms such as aural fullness, muffled hearing, and tinnitus, coupled with the historical absence of standardized diagnostic criteria [8]. This diagnostic gap often delays appropriate treatment, increasing the risk of complications. Untreated ETD progresses to OME in 30–40% of cases, chronic tympanic membrane retraction in 15–25%, and cholesteatoma development in 5–10% of patients with long-standing dysfunction [9]. The seven-item Eustachian Tube Dysfunction Questionnaire (ETDQ-7) addresses this diagnostic challenge by providing a validated, symptom-based assessment tool that facilitates early detection, monitors treatment response, and quantifies symptom burden [10]. Each item is rated on a seven-point Likert scale, yielding scores ranging from 7 to 49, with scores ≥ 14.5 indicating clinically significant dysfunction [10,11]. The ETDQ-7 has demonstrated excellent reliability (Cronbach’s alpha > 0.9) and has been validated in multiple languages including Arabic [12]. However, certain limitations merit consideration, including potential interpretation challenges for low-literacy populations and the absence of differentiation between acute and chronic ETD [10]. Regional studies in Saudi Arabia have reported variable ETD prevalence rates: 42.5% in Jeddah [13], 41.3% in Al-Madinah [14], 21.1% in Taif [15], and 12.2% in Qassim [16]. These disparities likely reflect differences in sampling methodologies, population characteristics, and environmental factors. Key risk factors identified include environmental exposures, allergic conditions, anatomical anomalies, and recurrent upper respiratory infections—all of which impair mucociliary function and tubal patency [17,18]. Environmental pollution represents a particularly relevant concern in Saudi Arabia, where major cities exceed World Health Organization (WHO) PM2.5 guidelines. Riyadh and Jeddah record PM2.5 levels of 12.8 μg/m3 and 12.0 μg/m3, respectively, substantially above the WHO annual mean recommendation of 5 μg/m3 [19,20]. Additionally, smoking prevalence remains significant in Saudi Arabia, with rates of 21.3% in Jeddah and 18.7% in Riyadh [21]. Furthermore, approximately 70% of patients with chronic middle ear conditions report concurrent ETD symptoms, highlighting the interconnection between ETD and severe otological pathology [22].
Despite the above findings, comprehensive regional data on ETD in the Saudi population remain limited, restricting a clear understanding of the true population burden and the relative contribution of associated risk factors. To address this gap, the present study aimed to (1) determine the nationwide prevalence of ETD among Saudi adult population using the ETDQ-7, (2) identify demographic, clinical, and lifestyle factors associated with ETD, and (3) compare the consistency between subjective ETDQ-7 scores and general subjective symptom reporting to assess diagnostic awareness. It is hypothesized that demographic, clinical, and lifestyle factors are significantly linked with ETD prevalence, and that ETDQ-7 scores may correlate with patients’ self-reported symptoms, reflecting reliable diagnostic awareness. This approach offers novel insights compared with previous regional studies and may help in informed healthcare planning, screening, and preventive strategies for high-risk populations.

2. Materials and Methods

2.1. Study Design and Setting

This cross-sectional study was conducted across all five geographic regions of Saudi Arabia (Central, Eastern, Western, Northern, and Southern) between September 2024 and March 2025. The study employed a convenience sampling approach with strategic efforts to ensure broad geographic and demographic representation through multi-channel recruitment.

2.2. Participants and Sampling

The target population comprised Saudi adults aged ≥18 years residing in Saudi Arabia. Inclusion criteria required participants to be at least 18 years old, provide informed consent, and complete at least 90% of the questionnaire items. Exclusion criteria included individuals under 18 years, those unable to provide consent, and participants with >10% incomplete responses. Sample size calculation was based on the estimated Saudi population of 35 million with approximately 65% adults (22.75 million) [23]. Using Raosoft software with an expected ETD prevalence of 50% (to maximize sample size), 95% confidence level, 5% margin of error, and accounting for 10% non-response rate, the minimum required sample was 385 participants. To enhance statistical power for subgroup analyses and improve representativeness across diverse demographic strata, the target sample was increased to 1124 participants. Recruitment utilized multiple channels to maximize reach and minimize selection bias: digital dissemination through social media platforms (WhatsApp, Twitter/X). The monitoring of the geographical depiction of the sample population was conducted by obtaining self-reported geographical data from the survey participants at the time of survey completion. The number of responses from each geographical area was tracked and evenly distributed to ascertain equitable geographical representation. Finally, demographic data and geographical region were analyzed simultaneously to maintain both diversity and proportional representation within the study cohort.

2.3. Data Collection Instrument

Data was collected using a validated, structured Arabic-language questionnaire adapted from previous research [13]. The questionnaire comprised four sections:
Section 1 (Sociodemographic characteristics): Twelve items assessing age, gender, nationality, region of residence, urban versus rural setting, nature of residence (coastal/mountainous/plain), educational level, employment status, marital status, and monthly income in Saudi Riyals (SAR).
Section 2 (Anthropometric and general health): Eight items evaluating self-reported weight, height, body mass index (BMI), physical activity level (categorized as none, irregular [<30 min five times weekly], or regular [≥30 min five times weekly]), smoking status (never, current, former), and physician-diagnosed diabetes mellitus, hypertension, and heart disease.
Section 3 (Clinical and surgical history): Six items documenting personal and family history of hearing loss, history and type of weight-loss surgery (bypass or gastric sleeve), presence of allergies, and specific allergic conditions (allergic rhinitis, asthma, gastroesophageal reflux disease).
Section 4 (ETD assessment): The validated Arabic version of the ETDQ-7 [12] alongside questions regarding self-reported ETD diagnosis. The ETDQ-7 translation followed rigorous forward–backward translation methodology with expert review to ensure cultural and content validity [12]. Each of the seven ETDQ-7 items was rated on a seven-point Likert scale (1 = no problem to 7 = severe problem), yielding total scores ranging from 7 to 49. A mean item score ≥ 2.5 or total score ≥ 14.5 was considered indicative of ETD, consistent with established diagnostic thresholds [10,11]. Severity classification categorized participants as normal (ETDQ-7 < 14.5), mild-to-moderate (14.5–24.9), or severe (≥25) [10]. Pilot testing with 30 participants confirmed good reliability (Cronbach’s alpha = 0.87), consistent with the established internal consistency of ETDQ-7 (Cronbach’s alpha > 0.9) [10,12].

2.4. Statistical Analysis

Following data collection, responses were exported to Microsoft Excel (Microsoft Corporation, Redmond, WA, USA) for data cleaning, error checking, duplicate removal, and preliminary screening for completeness. All statistical analyses were performed using R software (version 4.2.3; R Foundation for Statistical Computing, Vienna, Austria). Descriptive statistics summarized participant characteristics using means and standard deviations for continuous variables and frequencies with percentages for categorical variables. ETD prevalence was calculated as the proportion of participants with ETDQ-7 scores ≥ 14.5, with 95% confidence intervals. Stratified prevalence estimates were computed across demographic and clinical subgroups, with chi-square tests assessing between-group differences.
Multiple linear regression analysis identified independent predictors of ETDQ-7 scores (treated as a continuous outcome variable). All predictor variables were entered simultaneously into the model to control for potential confounding. Model fit was evaluated using R2, adjusted R2, and F-statistics. A sensitivity analysis excluding participants with bypass surgery was conducted to assess the robustness of other predictors. Statistical significance was set at p < 0.05 for all analyses. The completeness of the questionnaire was assessed for each patient, and any missing responses were documented. Cases with incomplete data were removed during the analysis.

2.5. Ethical Considerations

The study protocol received approval from the Research Ethics Committee of Jazan University (REC-46/02/1166, approved 1 September 2024). The study adhered to the Declaration of Helsinki principles, with written informed consent obtained from all participants prior to enrollment. Participation was entirely voluntary and anonymous, with participants retaining the right to withdraw at any point without consequences. Data confidentiality and anonymity were strictly maintained throughout the study period, with secure data storage and access limited to authorized research personnel only.

3. Results

3.1. Sociodemographic Characteristics

The study included 1124 participants, predominantly female (69%) and Saudi nationals (94%), with a mean age of 32 ± 13 years. Geographically, 35% resided in the western region, 25% in the southern, 19% in the central, 12% in the eastern, and 9% in the northern regions. Most participants lived in urban areas (87%), with 52% inhabiting plains, 25% coastal zones, and 23% mountainous regions. Education levels varied: 59.9% held bachelor’s degrees or diplomas, 31.6% had high school education or less, and around 9% possessed master’s or doctoral qualifications. Employment status revealed 40% were employed, 39% were students, and 21% were unemployed. Marital status distributions included 52% unmarried or engaged, 44% married, and 4% divorced or widowed. Monthly income disparities were notable, with approximately 46% earning <5000 SAR, 18.6% earning 5000–9999 SAR, and 17.5% and 18.1% earning 10,000–14,999 SAR and ≥15,000 SAR, respectively (Table 1).

3.2. Anthropometric Measures and Health Characteristics

The participants had a mean BMI of 25 ± 5.9 kg/m2, with nearly half (48%) in the normal weight range and 45% overweight or obese. In terms of physical exercise, 28% met recommended activity levels. The majority were non-smokers (87%). Among comorbidities, 8% of patients reported that they had diabetes, while 10% had hypertension (Table 2).

3.3. Clinical and Surgical Factors Associated with ETD

Clinical histories revealed that 4% of participants had personal hearing loss, while 25% reported a family history of hearing loss. Weight-loss surgery was reported by 4.3% of participants, including 0.7% who had undergone bypass surgery and 3.6% who had undergone gastric sleeve surgery. Allergies were reported by 33.6% of participants, with the most common types being allergic rhinitis (10.5%), asthma (6.2%), and gastroesophageal reflux disease (GERD) (4.4%) (Table 3).

3.4. Prevalence of Eustachian Tube Dysfunction

Based on ETDQ-7 scores (mean: 13 ± 7.1), the overall prevalence of ETD was 33.9% (95% CI: 31.1–36.8%), with 381 participants meeting the diagnostic threshold (ETDQ-7 score ≥ 14.5). In contrast, only 7% (n = 84) of participants self-reported ETD-related symptoms, indicating substantial underdiagnosis. Severity stratification classified 66.1% (n = 743) as normal (ETDQ-7 score < 14.5), 29.6% (n = 333) as mild to moderate ETD (ETDQ-7 score 14.5–24.9), and 4.3% (n = 48) as severe ETD (ETDQ-7 score ≥ 25) (Table 4, Figure 1a,b).

3.5. ETD Prevalence Stratified by Key Characteristics

ETD prevalence varied significantly across BMI categories, with obese participants showing the highest rates (42.4%) compared to normal-weight individuals (29.9%; p = 0.003). Similarly, participants with allergies had substantially higher ETD prevalence (49.2%) compared to those without allergies (26.5%; p < 0.001). Parameters including gender, residence, region, physical activity and smoking status showed no significant differences (p > 0.05) (Table 5).

3.6. Predictors of ETD Severity

Multiple linear regression analysis identified several significant independent predictors of ETDQ-7 scores. Higher BMI was associated with elevated ETD scores (β = 0.08; 95% CI: 0.03–0.16; p = 0.049), translating to approximately a 0.4-point increase in ETDQ-7 score for every 5-unit BMI increase. Family history of hearing loss was strongly associated with higher ETD scores (β = 1.87; 95% CI: 0.90–2.83; p < 0.001), representing an increase of approximately 13% of one standard deviation in ETDQ-7 scores. Prior bypass surgery showed the largest effect size (β = 14.37; 95% CI: 3.33–25.41; p = 0.011); however, this finding should be exploratory and interpreted with caution given the small sample size (n = 8, 0.7% of cohort) and wide confidence interval. The presence of allergies emerged as a strong predictor, with allergy diagnosis associated with a 3.19-point increase in ETDQ-7 score (95% CI: 2.30–4.07; p < 0.001) (Table 6). Detailed findings are presented in Appendix A (Table A1).

3.7. Sensitivity Analysis

A sensitivity analysis excluding participants who underwent bypass surgery (n = 8) was conducted to assess the robustness of other predictors. The associations for BMI (β = 0.08, p = 0.051), family history of hearing loss (β = 1.85, p < 0.001), and allergies (β = 3.17, p < 0.001) remained essentially unchanged, confirming the stability of these findings. Model fit improved slightly (Adjusted R2 = 0.121).

4. Discussion

4.1. Principal Findings and Prevalence Context

This study identified an ETD prevalence of 33.9% (95% CI: 31.1–36.8%) among Saudi adults based on validated ETDQ-7 assessment, substantially exceeding the 7% self-reported rate and revealing a 4.8-fold diagnostic gap. Independent risk factors included higher BMI, family history of hearing loss, prior bariatric bypass surgery, and allergies, whereas demographic characteristics, smoking, and common comorbidities showed no significant associations. These findings establish ETD as a major underdiagnosed public health concern in Saudi Arabia, affecting approximately one in three adults.
The observed prevalence substantially exceeds rates reported in Western populations, including 12.5% in the United States [24] and 19.8% in Germany [25], but aligns closely with regional Madinah [26]. It is also notably higher than a study from the Aseer region, which re-ported a much lower ETD prevalence of 4% [14]. This geographic pattern likely reflects environmental factors (arid climate, dust exposure, elevated air pollution), higher allergy prevalence (30–40% versus 20–25% in Western populations), and elevated obesity rates (35% in Saudi Arabia versus 27% in the United States) [19,20,27,28].

4.2. The Diagnostic Awareness Gap

The discrepancy between ETDQ-7-based diagnosis (33.9%) and self-reported symptoms (7%) represents a critical finding with substantial clinical implications. This 4.8-fold under-recognition parallels international observations, including a Turkish study where 31.2% met ETDQ-7 criteria yet only 6.8% self-reported symptoms [29], and an earlier Saudi study where only 9% of ETDQ-7-positive cases recognized their symptoms as abnormal [13]. This consistent pattern of underdiagnosis likely stems from multiple factors: gradual symptom onset leading to normalization, attribution of symptoms to alternative causes such as sinusitis or seasonal allergies, limited health literacy regarding ETD, and the nonspecific nature of symptoms (ear fullness, muffled hearing). The clinical significance is substantial, as undiagnosed ETD increases the risk of progressive complications, including chronic OME, tympanic membrane retraction, and cholesteatoma formation [9]. These findings strongly support implementing systematic ETDQ-7 screening in primary care settings.

4.3. Obesity as a Modifiable Risk Factor

Our analysis revealed that each 1-unit BMI increase was associated with a 0.08-point elevation in ETDQ-7 score (p = 0.049), translating to approximately a 0.4-point increase per 5-unit BMI increment. Stratified analysis demonstrated a dose–response relationship, with ETD prevalence increasing from 29.9% in normal-weight individuals to 42.4% in obese participants (p = 0.003). These findings align with established international evidence, including a U.S. cohort study demonstrating 12% higher ETD prevalence per BMI unit [30] and a German investigation showing 9.7% increased risk per BMI unit with obese individuals exhibiting 2.3-fold higher risk compared to normal-weight counterparts [31].
The pathophysiological mechanisms linking obesity to ETD are multifactorial. Adipose tissue secretes pro-inflammatory cytokines including leptin and interleukin-6, which promote mucosal edema and inflammation within the Eustachian tube [32]. Additionally, increased fat deposition in the parapharyngeal space may cause mechanical compression of the tubal ostium, impairing ventilation. These findings identify weight management as a potentially effective intervention for ETD prevention and symptom amelioration in populations with elevated obesity rates.

4.4. Allergies and Inflammatory Mechanisms

Allergy diagnosis emerged as the strongest predictor of ETD severity, with allergic individuals showing a 3.19-point ETDQ-7 score increase (p < 0.001), representing approximately 45% of one standard deviation change. Stratified analysis revealed ETD prevalence of 49.2% among allergic participants versus 26.5% in non-allergic individuals (p < 0.001). These findings corroborate established literature demonstrating 4.2-fold higher ETD odds in allergic patients [33] and 3.8-fold increased odds specifically for allergic rhinitis sufferers. The mechanistic basis is well-established: allergen exposure triggers IgE-mediated mast cell degranulation, releasing histamine and leukotrienes that induce mucosal inflammation, edema, and increased mucus production within the Eustachian tube. Given Saudi Arabia’s high burden of allergic diseases, particularly allergic rhinitis affecting 30–40% of adults [27,28], aggressive allergy management represents a promising avenue for reducing ETD prevalence.

4.5. Bariatric Surgery: A Novel Association

Bariatric bypass surgery demonstrated the largest effect size in the regression model (β = 14.37; 95% CI: 3.33–25.41; p = 0.011), indicating a novel but preliminary association due to the small sample size (n = 8, 0.7% of cohort) and wide confidence interval. Gastric sleeve surgery showed a similar, non-significant trend (β = 5.57; p = 0.266). Sensitivity analysis excluding bypass cases confirmed the stability of other predictors. These findings should be interpreted cautiously and require validation in larger prospective studies with objective ET function testing before clinical recommendations.

4.6. Genetic Predisposition and Family History

Those with family histories of hearing loss showed markedly higher ETDQ-7 scores (β = 1.87; 95% CI: 0.90–2.83; p < 0.001). Additional analysis found an ETD prevalence of 44.6% in those with a family history, compared to 30.3% without (p = 0.002). Previous research has explored possible genetic links to middle-ear conditions through COL11A2-related hearing loss and heritable estimates from twin studies [17,18]. However, caution is needed when interpreting the role of family history, given possible influences from shared environments, specific otologic health, or multifactorial risks. Nonetheless, a family history of hearing loss does appear to place individuals in a higher risk group, which may require increased surveillance, earlier intervention, or ETD diagnostic testing.

4.7. Null Findings and Clinical Implication

Several anticipated associations were notably absent in our analysis. Smoking status showed no significant relationship with ETD (p = 0.436), contrasting with U.S. data demonstrating 2.1-fold higher ETD risk among smokers [10]. This discrepancy likely reflects our cohort’s substantially lower smoking prevalence (8% versus 15% nationally in the U.S.) and younger mean age (32 versus 45 years in comparative studies), potentially limiting statistical power to detect this association. Similarly, no regional variation in ETD prevalence emerged (p = 0.189), despite documented differences in air quality across Saudi cities [19,20]. This unexpected finding may result from our predominantly urban sample (87%) obscuring geographic differences, or suggest that individual-level factors (BMI, allergies) exert stronger influence than environmental exposures in determining ETD risk. Furthermore, no significant associations were observed with age, gender, region of residence, nature of residence (coastal/mountainous/plain), education level, income, marital status, employment, smoking status, physical activity level, or comorbidities including diabetes mellitus, hypertension, or heart disease. This may reflect the low prevalence of these conditions in the cohort, limited statistical power, or the predominance of stronger predictors in the regression model, rather than a definitive absence of effects.

4.8. Strengths and Limitations

This study possesses several strengths: it represents the largest and most geographically comprehensive investigation of ETD in Saudi Arabia with nationwide representation (n = 1124); uses the validated Arabic ETDQ-7 for standardized assessment; identifies the novel bariatric surgery–ETD association; achieves high response rate (93%); and provides adequate statistical power. However, certain limitations should be acknowledged. Because of the cross-sectional design, the temporal relationship between potential predictors and ETD cannot be determined, and thus no causal inference can be made. Convenience sampling introduced may cause selection bias, with overrepresentation of urban (87%), young (mean age 32), and female (69%) participants relative to national demographics. This sampling bias may limit the generalizability of our findings, as the attitudes and behaviors of younger, urban, and predominantly female participants may not reflect the broader population. Therefore, observed associations particularly those based on self-reported measures and the small bypass-surgery (n = 8) subgroup warrants cautious interpretation of the results. Self-reported anthropometric measures may introduce bias, leading to BMI misclassification and affecting observed associations. As the regression model’s R2 is low (0.14), it must be acknowledged that the predictors explain only a modest portion of the variance, suggesting that other unmeasured factors may play a substantial role. Future studies could address this by using objectively measured data or validating self-reports values of sample.

4.9. Clinical and Public Health Implications

These findings carry substantial implications for clinical practice and public health policy in Saudi Arabia. The high prevalence (33.9%) combined with marked underdiagnosis (4.8-fold gap) justifies implementing systematic ETDQ-7 screening in primary care settings, particularly for high-risk groups, including obese individuals, allergy sufferers, bariatric surgery patients, and those with family history of hearing loss. The identification of modifiable risk factors—particularly obesity and allergies—provides clear targets for preventive interventions. Weight management programs and aggressive allergy management may improve ETD symptoms and reduce prevalence. For healthcare providers, these findings emphasize comprehensive otological assessment in patients presenting with nonspecific auditory symptoms. Post-bariatric surgery patients warrant specific attention for ETD surveillance. Future research priorities should include prospective cohort studies establishing temporal relationships, mechanistic investigations, intervention trials evaluating weight loss and allergy treatment efficacy, and validation studies incorporating objective Eustachian tube function testing.

5. Conclusions

This regional study demonstrates ETD as a highly prevalent but underdiagnosed condition in the Saudi population, with significant gaps in symptom recognition. Key risk factors, such as obesity, allergies, bariatric surgery, and family history, suggest opportunities for targeted interventions, including routine ETDQ-7 screening, weight management, allergy control, post-bariatric follow-up, and public awareness campaigns. The observed association between bariatric surgery and ETD was preliminary, but it recommends further research and may inform standardized surgical counseling. Future investigation should focus on prospective studies and intervention trials to guide prevention and management strategies.

Author Contributions

Conceptualization: M.A.J., R.A.J. and A.A.O. (Abdulrahman A. Otaif); methodology: M.A.J., R.A.J. and A.A.O. (Abdulelah A. Otaif); software: M.A.J.; validation: M.A.J., M.S.M. and R.W.A.N.; formal analysis: M.A.J.; investigation: R.A.J., A.A.O. (Abdulrahman A. Otaif), A.A.O. (Abdulelah A. Otaif), A.A.D., M.S.M., R.W.A.N., Y.A.M., A.Y.M., A.M., W.M., F.H. and S.A.H.D.; resources: M.A.J., A.M. and W.M.; data curation: R.A.J., A.A.O. (Abdulelah A. Otaif), A.A.O. (Abdulrahman A. Otaif) and A.A.D.; writing—original draft preparation: M.A.J., R.A.J., A.A.O. (Abdulrahman A. Otaif), A.A.O. (Abdulelah A. Otaif) and A.A.D.; writing—review and editing: M.A.J., M.A.R., A.A.B., M.S.M., R.W.A.N., A.M. and W.M.; visualization: M.A.J.; supervision: M.A.J., M.A.R., A.A.B. and A.M.; project administration: M.A.J. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Vice Deanship of Scientific Research Chairs, King Saud University, Saudi Arabia; Research Chair of Epidemiology and Public Health.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Committee of Jazan University (REC-46/02/1166, approved on 1 September 2024).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study, and all data was anonymized prior to analysis.

Data Availability Statement

The data presented in this study is available on request from the corresponding author. The data is not publicly available due to ethical restrictions and privacy concerns related to sensitive health information.

Acknowledgments

The authors acknowledge the Vice Deanship of Scientific Research Chairs, King Saud University, Saudi Arabia; Research Chair of Epidemiology and Public Health for funding this project. Generative AI tools (OpenAI GPT-5) were utilized solely for language refinement and proofreading. All research content and conclusions were independently developed and verified by the authors.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
BMIBody Mass Index
ETEustachian Tube
ETDEustachian Tube Dysfunction
ETDQ-7Eustachian Tube Dysfunction Questionnaire-7
GERDGastroesophageal Reflux Disease
OMEOtitis Media with Effusion

Appendix A

Table A1. Determinants of ETD: Multiple linear regression analysis (all variables).
Table A1. Determinants of ETD: Multiple linear regression analysis (all variables).
Predictorsβ95% CIp-Value
(Intercept)9.916.38–13.43<0.001
Anthropometric   
BMI (per kg/m2)0.080.03–0.160.049
Demographic Factors   
Age (per year)0.01−0.04–0.060.743
Gender (ref: Female)   
Male−0.32−1.35–0.700.536
Nationality (ref: Non-Saudi)   
Saudi−0.05−1.78–1.680.955
Geographic Factors   
Region (ref: Central)   
Eastern region−1.29−2.89–0.300.113
Northern region−1.17−2.86–0.520.174
Southern region−1.19−2.65–0.280.112
Western region−0.70−2.05–0.650.309
Residence (ref: Rural)   
Urban−0.47−1.91–0.980.525
Nature of residence (ref: Plain)   
Coastal0.04−1.06–1.140.938
Mountainous0.64−0.57–1.850.299
Socioeconomic Factors   
Education (ref: High school or lower)   
Bachelor’s or Diploma0.59−0.40–1.590.241
Master’s or PhD1.29−0.50–3.090.157
Monthly Income (ref: <5000 SAR)   
5000–99990.42−0.85–1.690.519
10,000–14,9990.90−0.44–2.230.190
≥15,0000.32−1.08–1.720.653
Occupation (ref: Unemployed)   
Employed−0.40−1.58–0.780.507
Student0.10−1.37–1.560.898
Marital status (ref: Non-married/Engaged)   
Married−1.03−2.39–0.330.137
Divorced/Widow0.62−1.80–3.040.615
Lifestyle Factors   
Smoking status (ref: Never)   
Current smoker−0.65−2.29–0.990.436
Former smoker−0.08−2.02–1.860.934
Physical activity (ref: None)   
Regular (≥30 min, 5×/week)−0.28−1.23–0.670.567
Irregular (<30 min, 5×/week)−0.01−1.08–1.060.983
Clinical Factors   
Personal hearing loss (ref: No)   
Yes1.98−0.38–4.340.101
Family history hearing loss (ref: No)   
Yes1.870.90–2.83<0.001
Weight-loss surgery type (ref: None)   
Bypass surgery14.373.33–25.410.011 *
Gastric sleeve surgery5.57−4.26–15.410.266
Allergy (ref: No)   
Yes3.192.30–4.07<0.001
Comorbidities   
Diabetes Mellitus (ref: No)   
Yes−0.46−2.19–1.280.606
Hypertension (ref: No)   
Yes−0.35−1.97–1.260.667
Heart Disease (ref: No)   
Yes−0.31−2.69–2.070.800
Model Fit Statistics   
R20.143  
Adjusted R20.118  
F-statistic5.71 (p < 0.001)  
Sample size1124  
* Statistically significant (p < 0.05).

References

  1. Casale, J.; Shumway, K.R.; Hatcher, J.D. Physiology, Eustachian Tube Function. In StatPearls [Internet]; StatPearls Publishing: Treasure Island, FL, USA, 2025. [Google Scholar] [PubMed]
  2. Rahman, T.; Rahman, M.; Hossain, M.A.; Jewel, A.M. Comparison of Eustachian tube function by impedance audiometry and correlation results with tympanoplasty. Int. J. 2024, 6, 10–13. [Google Scholar] [CrossRef]
  3. Schilder, A.G.; Bhutta, M.F.; Butler, C.C.; Holy, C.; Levine, L.H.; Kvaerner, K.J.; Norman, G.; Pennings, R.J.; Poe, D.; Silvola, J.T.; et al. Eustachian tube dysfunction: Consensus statement on definition, types, clinical presentation and diagnosis. Clin. Otolaryngol. 2015, 40, 407–411. [Google Scholar] [CrossRef]
  4. Yu, X.; Zhang, H.; Zong, S.; Xiao, H. Allergy in pathogenesis of eustachian tube dysfunction. World Allergy Organ. J. 2024, 17, 100860. [Google Scholar] [CrossRef]
  5. Fallon, K.; Remenschneider, A. Understanding Eustachian tube dysfunction. JAMA Otolaryngol. Head Neck Surg. 2025, 151, 89. [Google Scholar] [CrossRef]
  6. Shan, A.; Ward, B.K.; Goman, A.M.; Betz, J.F.; Reed, N.S.; Poe, D.S.; Nieman, C.L. Prevalence of Eustachian tube dysfunction in adults in the United States. JAMA Otolaryngol. Head Neck Surg. 2019, 145, 974–975. [Google Scholar] [CrossRef]
  7. Pradhan, A.; Vescan, A.; Lee, J.W. Eustachian tube dysfunction in adults. Can. Med. Assoc. J. 2025, 197, E1227. [Google Scholar] [CrossRef]
  8. Nastasiadou, S.; Bountzis, P.; Gkogkos, D.E.; Karkos, P.; Constantinidis, J.; Triaridis, S.; Psillas, G. Eustachian Tube Dysfunction Diagnostic Pathway-What Is the Current State of the Art and How Relevant Is Chronic Nasal Disease? J. Clin. Med. 2024, 13, 3700. [Google Scholar] [CrossRef] [PubMed]
  9. Smith, M.E.; Takwoingi, Y.; Deeks, J.; Alper, C.; Bance, M.L.; Bhutta, M.F.; Donnelly, N.; Poe, D.; Tysome, J.R. Eustachian tube dysfunction: A diagnostic accuracy study and proposed diagnostic pathway. PLoS ONE 2018, 13, e0206946. [Google Scholar] [CrossRef] [PubMed]
  10. Teixeira, M.S.; Swarts, J.D.; Alper, C.M. Accuracy of the ETDQ-7 for Identifying Persons with Eustachian Tube Dysfunction. Otolaryngol. Head Neck Surg. 2018, 158, 83–89. [Google Scholar] [CrossRef] [PubMed]
  11. Schröder, S.; Lehmann, M.; Sauzet, O.; Ebmeyer, J.; Sudhoff, H. A novel diagnostic tool for chronic obstructive eustachian tube dysfunction—The eustachian tube score. Laryngoscope 2015, 125, 703–708. [Google Scholar] [CrossRef]
  12. Alkholaiwi, F.; Alnatheer, A.M.; Theyab, R.S.; Alyousef, M.; Aldrees, T.; Dahmash, A.B.; Alghonaim, Y. Cross-Cultural Adaptation, Validation, and Arabic Translation of the Eustachian Tube Dysfunction Questionnaire (ETDQ-7). Int. Arch. Otorhinolaryngol. 2022 , 26, e636–e642. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  13. Alshehri, K.A.; Saggaf, O.M.; Alshamrani, H.M.; Alnefaie, A.M.; Alghamdi, K.B. Prevalence of and Factors Associated With Eustachian Tube Dysfunction Among the Public in Jeddah, Saudi Arabia: Cross-Sectional Survey-Based Study. Interact J. Med. Res. 2020 , 9, e14640. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  14. Alshamani, M.R.; Alandijani, H.A.; Alhussaini, O.M.; Alharbi, R.A.; Almeshaly, S.S.; Alraddadi, A.F.; Zakareya, B.F.; Alrehaili, R.D.; Alkenani, F.A.; Jorob, S.M. Prevalence of Eustachian Tube Dysfunction and Its Associated Factors Among the General Public in Al-Madinah, Saudi Arabia. Cureus 2023 , 15, e33748. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  15. Altalhi, W.A.; Alsulaimani, A.I.; Alhossaini, Z.A.; Alharthi, R.M.; Almalki, Z.A.; Altalhi, W.A.; Alswat, S.H.; Alnefaie, G.O. Prevalence of and Factors Associated With Eustachian Tube Dysfunction Among the Public in Taif, Saudi Arabia. Cureus 2022 , 14, e27482. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  16. Almutairi, A.; Alharbi, B.A.; Alharbi, M.T.; Al-Sowinea, A.F.; Alshammakhi, A.M.; Munhish, F.A.; Al-Harbi, A.M.; Alabdulrahim, J.M. Symptoms and Factors Associated With Eustachian Tube Dysfunction Among the Population of Qassim, Saudi Arabia. Cureus 2024 , 16, e61087. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  17. Bal, R.; Deshmukh, P. Management of Eustachian Tube Dysfunction: A Review. Cureus 2022, 14, e31432. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  18. Kim, H.Y. Eustachian Tube Dysfunction in Hearing Loss: Mechanistic Pathways to Targeted Interventions. Biomedicines 2025 , 13, 2686. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  19. Khodeir, M.; Shamy, M.; Alghamdi, M.; Zhong, M.; Sun, H.; Costa, M.; Chen, L.C.; Maciejczyk, P. Source apportionment and elemental composition of PM2.5 and PM10 in Jeddah City, Saudi Arabia. Atmos. Pollut. Res. 2012, 3, 331–340. [Google Scholar] [CrossRef] [PubMed]
  20. World Health Organization. WHO Global Air Quality Guidelines: Particulate Matter (PM2.5 and PM10), Ozone, Nitrogen Dioxide, Sulfur Dioxide and Carbon Monoxide; World Health Organization: Geneva, Switzerland, 2021. [Google Scholar]
  21. Ministry of Health, Saudi Arabia. Saudi Health Interview Survey: Results of Health-Related Behaviors; Ministry of Health: Riyadh, Saudi Arabia, 2022. [Google Scholar]
  22. Masalha, M.; Shlizerman, L.; Mazzawi, S.; Handzel, O.; Kassem, F.; Briscoe, D.; Siag, K. Impact of Otorrhea and Positive Cultures on Tympanoplasty Outcomes. Isr. Med. Assoc. J. 2023 , 25, 42–46. [Google Scholar] [PubMed]
  23. General Authority for Statistics. Population Estimates in the Mid-Year 2023; General Authority for Statistics: Riyadh, Saudi Arabia, 2023. [Google Scholar]
  24. Swarts, J.D.; Alper, C.M.; Luntz, M.; Bluestone, C.D.; Doyle, W.J. Eustachian tube function in adults without middle ear disease. Ann. Otol. Rhinol. Laryngol. 2015, 124, 220–225. [Google Scholar] [CrossRef]
  25. Schröder, S.; Lehmann, M.; Ebmeyer, J.; Upile, T.; Sudhoff, H. Balloon Eustachian tuboplasty: A retrospective cohort study. Clin. Otolaryngol. 2015 , 40, 629–638. [Google Scholar] [CrossRef] [PubMed]
  26. Alshehri, A.; Bukhari, L.K.; Almasswary, S.A.; Alotaibi, S.M.; AlQahatani, R.Y.; Althumairy, H.A.; Al Mudawi, E.A. Prevalence of Eustachian Tube Dysfunction and Its Associated Factors among the General Public in Aseer Region, Saudi Arabia. World Fam. Med./Middle East J. Fam. Med. 2024, 22, 31–36. [Google Scholar] [CrossRef]
  27. Al-Ghobain, M.O.; Al-Hajjaj, M.S.; Al-Moamary, M.S. Asthma prevalence among 16- to 18-year-old adolescents in Saudi Arabia using the ISAAC questionnaire. BMC Public Health 2012, 12, 239. [Google Scholar] [CrossRef]
  28. Moradi-Lakeh, M.; El Bcheraoui, C.; Tuffaha, M.; Daoud, F.; Al Saeedi, M.; Basulaiman, M.; Memish, Z.A.; AlMazroa, M.A.; Al Rabeeah, A.A.; Mokdad, A.H. Prevalence of asthma in Saudi adults: Findings from a national household survey, 2013. BMC Pulm. Med. 2015, 15, 77. [Google Scholar] [CrossRef]
  29. Cayir, S.; Hizli, O.; Kayabasi, S.; Yildirim, G. Eustachian tube dysfunction in sleep apnea patients and improvements afforded by continuous positive airway pressure therapy. Braz. J. Otorhinolaryngol. 2021 , 87, 333–337. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  30. Mehta, N.K.; Ma, C.; Nguyen, S.A.; McRackan, T.R.; Meyer, T.A.; Lambert, P.R. Medical Management for Eustachian Tube Dysfunction in Adults: A Systematic Review and Meta-Analysis. Laryngoscope 2022 , 132, 849–856. [Google Scholar] [CrossRef] [PubMed]
  31. Alyahya, K.; Alarfaj, A.; AlBahr, A.; AlBahar, S.; Alsaleh, M.; Almuhaytib, F.; Alyahya, A. The impact of acute weight loss following bariatric surgery on Eustachian tube function. J. Med. Life 2023 , 16, 1375–1380. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  32. Mancuso, P. Obesity and lung inflammation. J. Appl. Physiol. 2010, 108, 722–728. [Google Scholar] [CrossRef] [PubMed]
  33. Fireman, P. Otitis media and eustachian tube dysfunction: Connection to allergic rhinitis. J. Allergy Clin. Immunol. 1997, 99, S787–S797. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (a) Prevalence of eustachian tube dysfunction (ETD) among participants, showing that 33.9% screened positive while 66.1% screened negative. (b) Severity classification of ETD based on ETDQ-7 scores, demonstrating that 66.1% had normal function, 29.6% had mild to moderate dysfunction, and 4.3% had severe dysfunction.
Figure 1. (a) Prevalence of eustachian tube dysfunction (ETD) among participants, showing that 33.9% screened positive while 66.1% screened negative. (b) Severity classification of ETD based on ETDQ-7 scores, demonstrating that 66.1% had normal function, 29.6% had mild to moderate dysfunction, and 4.3% had severe dysfunction.
Diagnostics 16 00086 g001
Table 1. Sociodemographic characteristics of study participants (n = 1124).
Table 1. Sociodemographic characteristics of study participants (n = 1124).
CharacteristicValue
Age, mean ± SD (years)32 ± 13
Sex, n (%) 
Male344 (31%)
Female780 (69%)
Nationality, n (%) 
Saudi1052 (94%)
Non-Saudi72 (6%)
Region, n (%) 
Central region212 (19%)
Eastern region134 (12%)
Northern region102 (9%)
Southern region279 (25%)
Western region397 (35%)
Residence, n (%) 
Rural143 (13%)
Urban981 (87%)
Nature of residence, n (%) 
Coastal278 (25%)
Mountainous257 (23%)
Plain589 (52%)
Education level, n (%) 
High School Degree or Lower355 (31.6%)
Bachelor’s or Diploma degree673 (59.9%)
Master’s or PhD96 (8.5%)
Employment status, n (%) 
Employed448 (40%)
Student440 (39%)
Unemployed236 (21%)
Marital status, n (%) 
Non-Married/Engaged586 (52%)
Married494 (44%)
Divorced/Widow44 (4%)
Monthly Income (SAR), n (%) 
<5000515 (45.8%)
5000–9999209 (18.6%)
10,000–14,999197 (17.5%)
≥15,000203 (18.1%)
Note: SD = Standard deviation; SAR = Saudi Riyal.
Table 2. Anthropometric measures, lifestyle factors, and comorbidities of study participants (n = 1124).
Table 2. Anthropometric measures, lifestyle factors, and comorbidities of study participants (n = 1124).
CharacteristicValue
Anthropometric Measures, mean ± SD 
Weight (kg)67 ± 17
Height (cm)163 ± 8.8
BMI (kg/m²)25 ± 5.9
BMI Categories (WHO), n (%) 
Underweight (<18.5)79 (7%)
Normal weight (18.5–24.9)539 (48%)
Overweight (25–29.9)315 (28%)
Obese (≥30)191 (17%)
Physical activity level, n (%) 
No regular activity578 (51.4%)
Regular (≥30 min, 5×/week)319 (28.4%)
Irregular (<30 min, 5×/week)227 (20.2%)
Smoking status, n (%) 
Never979 (87%)
Current smoker88 (8%)
Former smoker57 (5%)
Comorbidities, n (%) 
Diabetes Mellitus 
No1036 (92%)
Yes88 (8%)
Hypertension 
No1012 (90%)
Yes112 (10%)
Heart Disease 
No1081 (96%)
Yes43 (4%)
Note: SD = Standard deviation; BMI = Body mass index; WHO = World Health Organization.
Table 3. Clinical and surgical factors associated with eustachian tube dysfunction (n = 1124).
Table 3. Clinical and surgical factors associated with eustachian tube dysfunction (n = 1124).
Characteristicn (%) *
Personal history of hearing loss 
No1083 (96%)
Yes41 (4%)
Family history of hearing loss 
No844 (75%)
Yes280 (25%)
History of weight-loss surgery 
No1076 (96%)
Yes48 (4%)
Type of weight-loss surgery (n = 48) 
Bypass surgery8 (0.7%)
Gastric sleeve surgery40 (3.6%)
Presence of allergy 
No746 (66.4%)
Yes378 (33.6%)
Type of allergic condition (n = 378) 
Allergic rhinitis118 (10.5%)
Asthma70 (6.2%)
Gastroesophageal reflux disease (GERD)49 (4.4%)
Multiple allergic conditions141 (12.5%)
* Percentages for “Type of weight-loss surgery” and “Type of allergic condition” are calculated from total sample (n = 1124) for consistency.
Table 4. ETD diagnosis and severity classification (n = 1124).
Table 4. ETD diagnosis and severity classification (n = 1124).
CharacteristicValue
ETDQ-7 Score 
Mean ± SD13 ± 7.1
ETD Diagnosis (ETDQ-7 ≥ 14.5), n (%) 
No743 (66.1%)
Yes381 (33.9%)
Self-reported ETD symptoms, n (%) 
No1040 (93%)
Yes84 (7%)
ETD Severity Classification, n (%) 
Normal (ETDQ-7 < 14.5)743 (66.1%)
Mild to Moderate (ETDQ-7 14.5–24.9)333 (29.6%)
Severe (ETDQ-7 ≥ 25)48 (4.3%)
Discordance Rate 
ETDQ-7 * positive but self-report negative297 (26.4%)
Self-report positive but ETDQ-7 negative0 (0%)
* ETDQ-7 = Eustachian Tube Dysfunction Questionnaire-7.
Table 5. ETD prevalence stratified by demographic and clinical characteristics (n = 1124).
Table 5. ETD prevalence stratified by demographic and clinical characteristics (n = 1124).
CharacteristicETD Present n (%)ETD Absent n (%)p-Value *
Overall Prevalence381 (33.9%)743 (66.1%)-
Gender  0.304
Male109 (31.7%)235 (68.3%) 
Female272 (34.9%)508 (65.1%) 
Region  0.189
Central77 (36.3%)135 (63.7%) 
Eastern39 (29.1%)95 (70.9%) 
Northern30 (29.4%)72 (70.6%) 
Southern89 (31.9%)190 (68.1%) 
Western146 (36.8%)251 (63.2%) 
Residence  0.413
Rural44 (30.8%)99 (69.2%) 
Urban337 (34.4%)644 (65.6%) 
BMI Category (WHO)  0.003
Underweight (<18.5)22 (27.8%)57 (72.2%) 
Normal weight (18.5–24.9)161 (29.9%)378 (70.1%) 
Overweight (25–29.9)117 (37.1%)198 (62.9%) 
Obese (≥30)81 (42.4%)110 (57.6%) 
Allergy Status  <0.001
No allergy195 (26.5%)541 (73.5%) 
Allergy present186 (49.2%)192 (50.8%) 
Smoking Status  0.281
Never337 (34.4%)642 (65.6%) 
Current smoker25 (28.4%)63 (71.6%) 
Former smoker19 (33.3%)38 (66.7%) 
Physical Activity  0.187
No regular activity207 (35.8%)371 (64.2%) 
Regular (≥30 min, 5×/week)100 (31.3%)219 (68.7%) 
Irregular (<30 min, 5×/week)74 (32.6%)153 (67.4%) 
Family History of Hearing Loss  0.002
No256 (30.3%)588 (69.7%) 
Yes125 (44.6%)155 (55.4%) 
Weight-loss Surgery  0.029
No359 (33.4%)717 (66.6%) 
Yes22 (45.8%)26 (54.2%) 
* p-values calculated using chi-square test for categorical variables.
Table 6. Significant determinants of ETD: Multiple linear regression analysis (n = 1124).
Table 6. Significant determinants of ETD: Multiple linear regression analysis (n = 1124).
Predictorsβ95% CIp-Value
(Intercept)9.916.38–13.43<0.001
Anthropometric   
BMI (per kg/m2)0.080.03–0.160.049
Clinical Factors   
Family history of hearing loss (ref: No)   
Yes1.870.90–2.83<0.001
Weight-loss surgery type (ref: None)   
Bypass surgery14.373.33–25.410.011 *
Allergy (ref: No)   
Yes3.192.30–4.07<0.001
Model Fit Statistics   
R20.143  
Adjusted R20.118  
F-statistic5.71 (p < 0.001)  
Sample size1124  
* Statistically significant (p < 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jareebi, M.A.; Jahlan, R.A.; Otaif, A.A.; Otaif, A.A.; Daghreeri, A.A.; Mahnashi, M.S.; Al Nahwe, R.W.; Maslamani, Y.A.; Mashragi, A.Y.; Mawkili, A.; et al. Prevalence and Interplay of Modifiable and Genetic Determinants of Eustachian Tube Dysfunction Among Saudi Adults: A Nationwide Study. Diagnostics 2026, 16, 86. https://doi.org/10.3390/diagnostics16010086

AMA Style

Jareebi MA, Jahlan RA, Otaif AA, Otaif AA, Daghreeri AA, Mahnashi MS, Al Nahwe RW, Maslamani YA, Mashragi AY, Mawkili A, et al. Prevalence and Interplay of Modifiable and Genetic Determinants of Eustachian Tube Dysfunction Among Saudi Adults: A Nationwide Study. Diagnostics. 2026; 16(1):86. https://doi.org/10.3390/diagnostics16010086

Chicago/Turabian Style

Jareebi, Mohammad A., Riyadh A. Jahlan, Abdulrahman A. Otaif, Abdulelah A. Otaif, Abdulrahman A. Daghreeri, Mashael S. Mahnashi, Raghad W. Al Nahwe, Yahya A. Maslamani, Ali Y. Mashragi, Abdullah Mawkili, and et al. 2026. "Prevalence and Interplay of Modifiable and Genetic Determinants of Eustachian Tube Dysfunction Among Saudi Adults: A Nationwide Study" Diagnostics 16, no. 1: 86. https://doi.org/10.3390/diagnostics16010086

APA Style

Jareebi, M. A., Jahlan, R. A., Otaif, A. A., Otaif, A. A., Daghreeri, A. A., Mahnashi, M. S., Al Nahwe, R. W., Maslamani, Y. A., Mashragi, A. Y., Mawkili, A., Mawkili, W., Hakami, F., Darbashi, S. A. H., Ryani, M. A., & Bahri, A. A. (2026). Prevalence and Interplay of Modifiable and Genetic Determinants of Eustachian Tube Dysfunction Among Saudi Adults: A Nationwide Study. Diagnostics, 16(1), 86. https://doi.org/10.3390/diagnostics16010086

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop